MoneyWorks4Me

A fair growth of 17.37% in the revenue at Rs. 6194.50 millions was reported in the March 2026 quarter as compared to Rs. 5277.80 millions during year-ago period.Handsome Net Profit growth of 68.18% reported above the corresponding previous quarter figure of Rs. 531.80 millions to Rs. 316.20 millions.Operating profit for the quarter ended March 2026 rose to 943.10 millions as compared to 674.60 millions of corresponding quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 6194.50 5277.80 17.37 23190.60 20792.10 11.54 23190.60 20792.10 11.54
Other Income 17.40 45.20 -61.50 212.80 224.00 -5.00 212.80 224.00 -5.00
PBIDT 943.10 674.60 39.80 2903.70 2245.70 29.30 2903.70 2245.70 29.30
Interest 32.10 40.30 -20.35 145.50 147.60 -1.42 145.50 147.60 -1.42
PBDT 911.00 634.30 43.62 2646.10 2098.10 26.12 2646.10 2098.10 26.12
Depreciation 202.70 185.30 9.39 801.70 719.20 11.47 801.70 719.20 11.47
PBT 708.30 449.00 57.75 1844.40 1378.90 33.76 1844.40 1378.90 33.76
TAX 176.50 132.80 32.91 467.20 368.90 26.65 467.20 368.90 26.65
Deferred Tax 25.30 62.20 -59.32 61.70 121.50 -49.22 61.70 121.50 -49.22
PAT 531.80 316.20 68.18 1377.20 1010.00 36.36 1377.20 1010.00 36.36
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 15.22 12.78 19.11 12.52 10.80 15.93 12.52 10.80 15.93
Peers
Company Name CMP
Sun Pharma. Inds. 1842.55
Dr. Reddys Labs. 1141.00
Cipla 1366.30
Lupin 2075.00
Zydus Lifesciences 1113.45
View more..